Shanghai Kaibao Pharmaceutical (300039) — Cash Flow Quality Index
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow Quality Index of 2.93x as of September 2025. Operating cash flow of CN¥190.98 Million exceeds net income of CN¥65.09 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Shanghai Kaibao Pharmaceutical to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Kaibao Pharmaceutical Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Shanghai Kaibao Pharmaceutical across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Shanghai Kaibao Pharmaceutical to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year earnings quality comparison for Shanghai Kaibao Pharmaceutical. For live market cap and the full company financial profile, see Shanghai Kaibao Pharmaceutical (300039) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | CN¥278.95 Million | CN¥374.91 Million | ▼ -36.2% |
| 2023 | 1.17x | CN¥382.66 Million | CN¥327.87 Million | ▼ -41.1% |
| 2022 | 1.98x | CN¥376.42 Million | CN¥190.08 Million | ▲ +120.1% |
| 2021 | 0.90x | CN¥126.08 Million | CN¥140.11 Million | ▼ -61.9% |
| 2020 | 2.36x | CN¥250.65 Million | CN¥106.12 Million | ▲ +77.4% |
| 2019 | 1.33x | CN¥334.09 Million | CN¥250.99 Million | ▲ +15.1% |
| 2018 | 1.16x | CN¥262.36 Million | CN¥226.81 Million | ▲ +28.2% |
| 2017 | 0.90x | CN¥245.76 Million | CN¥272.30 Million | ▼ -19.0% |
| 2016 | 1.11x | CN¥314.88 Million | CN¥282.61 Million | ▼ -4.1% |
| 2015 | 1.16x | CN¥327.08 Million | CN¥281.65 Million | ▲ +43.7% |
| 2014 | 0.81x | CN¥282.38 Million | CN¥349.35 Million | ▼ -4.6% |
| 2013 | 0.85x | CN¥270.23 Million | CN¥318.82 Million | ▼ -15.6% |
| 2012 | 1.00x | CN¥243.32 Million | CN¥242.19 Million | ▲ +71.2% |
| 2011 | 0.59x | CN¥98.31 Million | CN¥167.56 Million | ▲ +266.8% |
| 2010 | 0.16x | CN¥19.79 Million | CN¥123.70 Million | ▼ -79.2% |
| 2009 | 0.77x | CN¥52.74 Million | CN¥68.67 Million | ▲ +136.8% |
| 2008 | 0.32x | CN¥18.70 Million | CN¥57.65 Million | ▼ -37.6% |
| 2007 | 0.52x | CN¥23.27 Million | CN¥44.81 Million | ▼ -45.0% |
| 2006 | 0.94x | CN¥19.70 Million | CN¥20.87 Million | — |